RT @BeeLeeLiberty: The subtext among researchers is: "is #remdesivir even anti-viral?!" How was everyone forced to get this drug as only li…
Remdesivir MATA MÁS que esa cohorte de placebo. Eso ES LO CONTRARIO de lo que se supone que un terapéutico debe hacer, pero FauxChi hace US$ con cada dosis administrada. Es por eso que lo empujó a la velocidad de la luz (AZT 2,0)
Remdesivir KILLS MORE than that placebo cohort. That’s is the OPPOSITE of what a therapeutic is supposed to do, yet FauxChi makes $ with each dose administered. That’s why he pushed it through at lightening speed (AZT 2.0) https://t.co/oltJQ0kpyr
RT @BradGeyer: The subtext among researchers is: "is #remdesivir even anti-viral?!" How was everyone forced to get this drug as only line o…
It's possible other studies in China were hader to control so better to suspend them. But this looks like feint and scant praise. https://t.co/lQCnF5LZL5 https://t.co/7WLFbT68Z1
The system to facilitate genocides and deny Americans early treatment and cures by "public health" agency killers like Fauci began in China with release of the C19 virus and this study. What does it say?https://t.co/lQCnF5LZL5 https://t.co/6SYMiDe8mS
RT @BradGeyer: The subtext among researchers is: "is #remdesivir even anti-viral?!" How was everyone forced to get this drug as only line o…
RT @BradGeyer: The subtext among researchers is: "is #remdesivir even anti-viral?!" How was everyone forced to get this drug as only line o…
RT @BradGeyer: The subtext among researchers is: "is #remdesivir even anti-viral?!" How was everyone forced to get this drug as only line o…
RT @BradGeyer: The subtext among researchers is: "is #remdesivir even anti-viral?!" How was everyone forced to get this drug as only line o…
RT @BradGeyer: The subtext among researchers is: "is #remdesivir even anti-viral?!" How was everyone forced to get this drug as only line o…
The subtext among researchers is: "is #remdesivir even anti-viral?!" How was everyone forced to get this drug as only line of defense. This is a criminal scheme. https://t.co/lQCnF5LZL5 https://t.co/wepkHoN0Tu
@BertrandBio Similar observation to what was observed in hospitalized, severe #COVID19 patients: no significant reduction in viral titers w #remdesivir treatment vs. placebo. https://t.co/g6xPAJ7c4H https://t.co/Fgf17ejrxW
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial - The Lancet https://t.co/n0Eb3E03Hr
“Remdesivir KILLS MORE than the placebo cohort. That’s the OPPOSITE of what a therapeutic is supposed to do, yet FauxChi makes $ with each dose. That’s why he pushed it through & placed it on hospitals 1st line of treatment in COVID. Dr Lynn Fynn ht
RT @zegaracr: @ChimpInABowTie @DrCraigWax1 Well now it kills more then placebo (8.6% more) https://t.co/6r7jT5If20 it is in the same study…
RT @zegaracr: @ChimpInABowTie @DrCraigWax1 Well now it kills more then placebo (8.6% more) https://t.co/6r7jT5If20 it is in the same study…
RT @bluemountnskies: Remdesivir KILLS MORE than that placebo cohort. That’s is the OPPOSITE of what a therapeutic is supposed to do, yet Fa…
Remdesivir KILLS MORE than that placebo cohort. That’s is the OPPOSITE of what a therapeutic is supposed to do, yet FauxChi makes $ with each dose administered. That’s why he pushed it through at lightening speed (AZT 2.0) and pushed it on hospitals. htt
RT @zegaracr: @ChimpInABowTie @DrCraigWax1 Well now it kills more then placebo (8.6% more) https://t.co/6r7jT5If20 it is in the same study…
Remdesivir KILLS MORE than that placebo cohort. That’s is the OPPOSITE of what a therapeutic is supposed to do, yet FauxChi makes $ with each dose administered. Dr Lynn Fynn https://t.co/kg09oNQP7M
RT @zegaracr: @ChimpInABowTie @DrCraigWax1 Well now it kills more then placebo (8.6% more) https://t.co/6r7jT5If20 it is in the same study…
RT @zegaracr: @ChimpInABowTie @DrCraigWax1 Well now it kills more then placebo (8.6% more) https://t.co/6r7jT5If20 it is in the same study…
@ChimpInABowTie @DrCraigWax1 Well now it kills more then placebo (8.6% more) https://t.co/6r7jT5If20 it is in the same study that got it "approved" table 3 day28 mortality (13.9%/12.8%)-1=+8.6% relative increase
@Valdieu @muntzer_thomas per quanto riguarda #Remdesivir, ci ho sperato anche io all'inizio della pandemia, avevo anche comprato azioni 😄Purtroppo, questo e altri studi ne hanno constatato la sostanziale inutilità: https://t.co/X4dfhHjwPc Se non addirittur
RT @keisuke4713: レムデシビルは入院期間を延長する 2020年2月6日から2020年3月12日まで中国10病院で無作為化二重盲検プラセボ対照試験 https://t.co/JyVXHpjCrQ レムデシビルが統計的有意効果なく、重篤な有害事象を起こした→早期中…
RT @keisuke4713: レムデシビルは入院期間を延長する 2020年2月6日から2020年3月12日まで中国10病院で無作為化二重盲検プラセボ対照試験 https://t.co/JyVXHpjCrQ レムデシビルが統計的有意効果なく、重篤な有害事象を起こした→早期中…
レムデシビルは入院期間を延長する 2020年2月6日から2020年3月12日まで中国10病院で無作為化二重盲検プラセボ対照試験 https://t.co/JyVXHpjCrQ レムデシビルが統計的有意効果なく、重篤な有害事象を起こした→早期中止すべきだった *ネットで少し話題になったが、一切、報道されず
@ALeftistPerspe1 @tolear1158 @Timcast Incorrect. Remdesivir is not associated with statistically significant clinical benefits. Look at the science. https://t.co/x96367hwmD
@En_kef @Technomagos @machiavelli_gr Φιλάκια καλο Σαββατοκύριακο δεν χρειαζομαι ψυχίατρο χτυπάω 10 χιλιόμετρα τρέξιμο την ημέρα και ειμαι μια χαρα https://t.co/J0D1MF1Hxa
RT @Nat_anest: Ремдесивир: исследование #1 Это небольшой тред о первом хорошо спланированном клиническом исследовании и применении Ремдеси…
This is the protocol for covid 🤔🤔something just feels…. Eeewwww
RT @al_jemima: @beckyamycare @OceanView71 Not sure if he was referring to this one, but the study was stopped due to adverse reactions from…
RT @al_jemima: @OceanView71 @tstreet13 @drmikehart This one? "Remdesivir was stopped early because of adverse events in 18 (12%) patients..…
@beckyamycare @OceanView71 Not sure if he was referring to this one, but the study was stopped due to adverse reactions from the drug. "Remdesivir was stopped early because of adverse events in 18 (12%) patients..." https://t.co/1t4rrfVg60
@OceanView71 @tstreet13 @drmikehart This one? "Remdesivir was stopped early because of adverse events in 18 (12%) patients..." https://t.co/1t4rrfVg60
RT @GG71902207: @PenguinClues @ecocentrism1 @LibResponse @HopeBegley China study of Remdesivir - Ineffective - FDA ignored it https://t.co…
@PenguinClues @ecocentrism1 @LibResponse @HopeBegley China study of Remdesivir - Ineffective - FDA ignored it https://t.co/PWlmbpDE1z
@cappsie @GidMK https://t.co/L7OPNDET7J Remdesivir is an approved treatment but science was not concrete on that despite the double blind study people say ivermectin lacks.
@TheLancet: "In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was not associated with statistically significant clinical benefits." https://t.co/7AyzlZnxDL @YoureAllDunces
@Anna1Mar1 @gabrielepx @strina_massimo @AurelianoStingi @borghi_claudio Quale evidenza? Questa? https://t.co/QqWJj2I3eC
RT @7thclouds: @19840615Ch @knkn3 #レムデシベル 英国治験結果。問題は「新型肺炎への治療効果有意性ない」点 2割に副作用低アルブミン。本研究で肺炎悪化の #副作用 なかった>“Remdesivir in adults with severe C…
RT @zegaracr: @CommoNurse1 @Fynnderella1 @Merck @Baric_Lab Pretty high on the list, i like the price row will see over time which will get…
@CommoNurse1 @Fynnderella1 @Merck @Baric_Lab Pretty high on the list, i like the price row will see over time which will get "approved" by federal drug dealer will they care about sideff. (w remdesivir that was not really an issue https://t.co/DpxpPCdTPM
RT @VincentRK: A trial from China published earlier also failed to show any significant benefit. @TheLancet https://t.co/mfcRojkhbk
A trial from China published earlier also failed to show any significant benefit. @TheLancet https://t.co/mfcRojkhbk
@BertrandBio No difference in viral load reduction also corroborates “underpowered” study by Wang et al. in @TheLancet from April 2020. https://t.co/g6xPAJoNth https://t.co/SfTVMRaBf6
Another study stopped their remdesivir clinical trial in patients with severe #COVID19 due to adverse events. https://t.co/3FxHkeQGij
@abcnews “remdesivir was not associated with statistically significant clinical benefits [and] the numerical reduction in time to clinical improvement in those treated earlier requires confirmation in larger studies.” https://t.co/BSXtzhlodU
7-6-2021: Remdesivir was useless in this new, 407-patient study https://t.co/9HLa7F35HN https://t.co/3BkvmkRbbF https://t.co/X6l0EHiW8n https://t.co/fmoCGINNPG https://t.co/IUyTSfhF2o https://t.co/CJbookg0eR https://t.co/Sho13I3vvT https://t.co/xSdmpZTb8D
@ShhhhDontTalk @MilaSirene @psychlyst1 @davidssinking @washingtonpost Sorry I’m old school. I like to read my research. https://t.co/yyFCHU07i1. I have more examples citing no improvements or high percentage of adverse events but I’m sure you will have an
RT @7thclouds: @19840615Ch @knkn3 英米いずれでも #レムデシベル の副作用に肺機能障害等深刻な副作用の報告はないが英国ランチェットは「#新型コロナウイルス への効果の有意性疑問 https://t.co/snJXIXA83p」「米国FDAはレム…
RT @7thclouds: @19840615Ch @knkn3 #レムデシベル 英国治験結果。問題は「新型肺炎への治療効果有意性ない」点 2割に副作用低アルブミン。本研究で肺炎悪化の #副作用 なかった>“Remdesivir in adults with severe C…
@olhardigital 2 - Em tempo, via @TheLancet: https://t.co/4ztIG5cUnX
7-6-2021: The 7-1-2021 remdesivir clinical trial by Rome, Italy's Alessandro Russo has now been upgraded to an "early access version" https://t.co/IUyTSfhF2o https://t.co/CJbookg0eR https://t.co/xSdmpZTb8D https://t.co/9HLa7F35HN https://t.co/Sho13I3vvT h
RT @raoult_didier: Deux études sur le remdesivir ont apporté leurs résultats : une publiée dans le Lancet, qui conclut à la non-efficacité…
@Flavr7 @strraffaella Per lei che si abbevera sui quotidiani e non sugli studi scientifici Studio remdesivir sospeso. Nessun miglioramento, 12% reazioni avverse (10 volte il vaccino) https://t.co/QqWJj2I3eC
8-13-2021: In a new, 145-patient study, remdesivir was useless: https://t.co/9HLa7F35HN https://t.co/3BkvmkRbbF https://t.co/X6l0EHiW8n https://t.co/fmoCGINNPG https://t.co/IUyTSfhF2o https://t.co/CJbookg0eR https://t.co/Sho13I3vvT https://t.co/xSdmpZTb8D
@kxl21 @veryvirology Chinese study lackluster not really anti-viral https://t.co/lQCnF5LZL5
@MarkEnnis Given that Remdesivir is an ineffective treatment not associated with statistically significant clinical benefits, it would be as if Andy Beshear's masks were found to be made out of cheese cloth..... https://t.co/YkKFFMoISS
@DavideDannato88 @jacoposcatizzi @ScaltritiLab No, sfortunatamente no Trial interrotto causa assenza di efficacia unita a controindicazioni nate nel gruppo di studio, invece assenti nel gruppo placebo Gli eventi avversi erano in sovrannumero rispetto agl
@hvyhttr_Dave @RizzleDizzle21 @washingtonpost R u saying that Congress got a briefing and weeks later Pelosi ignored it to invite ppl to Chinatown? I simply do not see her doing that. Also, IF Fauci knew that Remdesiver was THE covid treatment early on,
@RemiTell @MougeonLe @olivierveran L’étude n’était pas du tout bidon, d’ailleurs plein d’études ont confirmé le fait que le Remdesivir ne sert à rien contre le Covid. https://t.co/FqSQkyMKgQ
RT @MoniquePlaza3: Les validations du Remdesivir sont aux abonnés absents. Les résultats de Recovery et Discovery n’ont pas été publiés. De…
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
@AviBittMD Just look at the intro paragraph in the Lancet paper. Nothing but in vitro activity against SARS-CoV2 and animal studies against different coronaviruses: https://t.co/6v4BNWEGhw
The first Remdesivir study from China showing NO benefit! https://t.co/XQszMVvjPR
@LostTogetherCda @shawnsjames @CBSNews https://t.co/XQszMVvjPR. Even the WHO has recommended against the use of Remdesivir in COVID-19. https://t.co/y43RtbX1Na
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
4-22-2021: Remdesivir had zero efficacy vs. COVID-19 in the study just released today: https://t.co/9HLa7F35HN https://t.co/3BkvmkRbbF https://t.co/X6l0EHiW8n https://t.co/fmoCGINNPG https://t.co/IUyTSfhF2o https://t.co/CJbookg0eR https://t.co/Sho13I3vvT
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
RT @influenzer3: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/…
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/Sc3rkXpmT8 ・鼻咽頭スワブ(上段)および喀痰(下段)のウイルス量の検討。 RDVの抗ウイルス効果はなしという結果。 https://t.co/TycsKgnHqb